Interestingly, in the same study, it was reported that CLL patients with high expression of BCL-xL and low expression of miR-377 have an advanced tumor stage and a short survival estimation without treatment [78]. This evidence concerns the gene BCL2L1 and B-cell chronic lymphocytic leukemia.